The mIHC experiments revealed that compared to normal tissue, myxoma exhibited a higher proportion of CD8 + T cells expressing TOX and higher expression levels of GZMK while showing lower expression levels of GZMB (Fig. 4f), which confirmed the characteristic dysfunction of CD8 + T cells in myxoma. The gene discussed is GZMB; the disease is myxoma.